1 completed, 1 recruiting, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
Follow KeyBioscience AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis KBP-336, Placebo - Osteoarthritis in the Knee, Obesity | Phase 2 | Recruiting | KeyBioscience AG | 600 | 2025-01-28 | 2025-02-19 |
| A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM Daily injection of KBP/placebo for up to 28 days - Type II Diabetes Mellitus | Phase 1 | Terminated | KeyBioscience AG | 25 | 2018-04-17 | 2020-09-03 |
| Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes Daily injection of KBP/placebo for 12 weeks as add-on to metformin - Type 2 Diabetes Mellitus | Phase 2 | Completed | KeyBioscience AG | 255 | 2017-08-23 | 2018-09-11 |
Diabetes Mellitus, Type 2 (2) · Obesity (1) · Osteoarthritis (1) · Pain (1)
Czechia (2) · Denmark (2) · Moldova (2) · Poland (2) · Romania (2) · Germany (1) · Hong Kong (1) · United Kingdom (1)
Tim Heise, MD (1)
2017 (1)